Noah markewitz
@noahmarkewitz11.bsky.social
Internal Medicine Resident at Montefiore.
Interested in Med Ed and Nephrology
He/him
Interested in Med Ed and Nephrology
He/him
Reposted by Noah markewitz
Reharing my #shiny leaf plot app, demonstrating the relationship between prevalence/pre-test probability, sensitivity, specificity and post-test probabilities. lmsaxhaug.shinyapps.io/Leaf_App/ #rstats #meded #emimcc #cardiosky #medsky
November 17, 2025 at 9:50 AM
Reharing my #shiny leaf plot app, demonstrating the relationship between prevalence/pre-test probability, sensitivity, specificity and post-test probabilities. lmsaxhaug.shinyapps.io/Leaf_App/ #rstats #meded #emimcc #cardiosky #medsky
Reposted by Noah markewitz
1/ 🚨 NEW episode on venous congestion & the VExUS score 💧
Venous congestion is a century-old concept, but modern tools now allow clinicians to detect, quantify, and monitor it ‼️
🖥️: www.coreimpodcast.com/2025/11/19/v...
Venous congestion is a century-old concept, but modern tools now allow clinicians to detect, quantify, and monitor it ‼️
🖥️: www.coreimpodcast.com/2025/11/19/v...
November 19, 2025 at 12:02 PM
1/ 🚨 NEW episode on venous congestion & the VExUS score 💧
Venous congestion is a century-old concept, but modern tools now allow clinicians to detect, quantify, and monitor it ‼️
🖥️: www.coreimpodcast.com/2025/11/19/v...
Venous congestion is a century-old concept, but modern tools now allow clinicians to detect, quantify, and monitor it ‼️
🖥️: www.coreimpodcast.com/2025/11/19/v...
The way to get younger doctors back to the bedside is with data the physical exam finding outperforms other care. This is exactly what the ANDROMEDA shock 1 and 2 trial has done for capillary refill time. This is also the reason POCUS has brought younger docs back to the bedside!
The authors of a new review provide practical suggestions for clinical educators to reinvigorate the teaching and practice of bedside clinical skills in the modern health care environment. Learn more: nej.md/4nUirnP
#MedSky #MedEd
#MedSky #MedEd
November 17, 2025 at 8:33 PM
The way to get younger doctors back to the bedside is with data the physical exam finding outperforms other care. This is exactly what the ANDROMEDA shock 1 and 2 trial has done for capillary refill time. This is also the reason POCUS has brought younger docs back to the bedside!
A positive trial in cardiac prevention for HD patients, how cool is this!
In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo
@asnkidney.bsky.social | #KidneyWk
@asnkidney.bsky.social | #KidneyWk
November 8, 2025 at 5:22 AM
A positive trial in cardiac prevention for HD patients, how cool is this!
Such a cool study and further evidence on the funny and sad truth that hemodynamic shifts of dialysis actually worsen renal recovery
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury
This trial examines whether a conservative dialysis strategy can improve recovery of kidney function for patients with acute kidney injury who require dialysis.
jamanetwork.com
November 8, 2025 at 12:51 AM
Such a cool study and further evidence on the funny and sad truth that hemodynamic shifts of dialysis actually worsen renal recovery
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Love a well made sequel! But 10 percent absolute mortality decrease might have been asking for too much? Also why bicarb vs. no bicarb and not bicarb vs placebo? Have to wonder if no bicarb group received dialysis early because everyone knew they weren’t getting bicarb.
📢 Presented today in the #LIVES2025 Hot Topics session: Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: The BICARICU-2 Randomized Clinical Trial, from JAMA_current.
➡️ Free to read online:
ja.ma/4hRZXmF
➡️ Free to read online:
ja.ma/4hRZXmF
October 30, 2025 at 6:16 PM
Love a well made sequel! But 10 percent absolute mortality decrease might have been asking for too much? Also why bicarb vs. no bicarb and not bicarb vs placebo? Have to wonder if no bicarb group received dialysis early because everyone knew they weren’t getting bicarb.
Had so much to say about HRS we had to split it into two episodes!
Check out part 2 on HRS treatment, Transplant, and a topic near and dear to my heart, palliative care.
Check out part 2 on HRS treatment, Transplant, and a topic near and dear to my heart, palliative care.
1/ 🚨 NEW #5Pearls: Hepatorenal Syndrome Part ✌️
Let’s dive into treatment 🌊!
1️⃣ Vasoconstrictors
2️⃣ Albumin
3️⃣ Diuretics
Goal: raise MAP by 10-15 ‼️
🖥️: www.coreimpodcast.com/2025/10/22/h...
Let’s dive into treatment 🌊!
1️⃣ Vasoconstrictors
2️⃣ Albumin
3️⃣ Diuretics
Goal: raise MAP by 10-15 ‼️
🖥️: www.coreimpodcast.com/2025/10/22/h...
October 22, 2025 at 12:05 PM
Had so much to say about HRS we had to split it into two episodes!
Check out part 2 on HRS treatment, Transplant, and a topic near and dear to my heart, palliative care.
Check out part 2 on HRS treatment, Transplant, and a topic near and dear to my heart, palliative care.
Reposted by Noah markewitz
🆕🔥🔥CloCeBa RCT
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
October 19, 2025 at 4:34 AM
🆕🔥🔥CloCeBa RCT
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
Cloxacillin versus cefazolin for MSSA Bacteraemia
Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky
www.thelancet.com/journals/lan...
It has been a dream to be able to be a part of my favorite podcast.
Check out this very fun episode on one of the most interesting diseases, Hepatorenal Syndrome!
Check out this very fun episode on one of the most interesting diseases, Hepatorenal Syndrome!
1/ 🚨 NEW #5Pearls: Hepatorenal Syndrome (HRS) part 1️⃣
AKI + portal HTN 🟰hepatorenal syndrome
🖥️: www.coreimpodcast.com/2025/10/15/h...
AKI + portal HTN 🟰hepatorenal syndrome
🖥️: www.coreimpodcast.com/2025/10/15/h...
October 15, 2025 at 11:19 AM
It has been a dream to be able to be a part of my favorite podcast.
Check out this very fun episode on one of the most interesting diseases, Hepatorenal Syndrome!
Check out this very fun episode on one of the most interesting diseases, Hepatorenal Syndrome!
Excited to share a new case report from my time in the CCU… we present a multidisciplinary management of a RCA STEMI complicated by cardiogenic shock, severe mitral regurgitation, and complete heart block.
www.jacc.org/doi/abs/10.1...
www.jacc.org/doi/abs/10.1...
Multidisciplinary Management and Hemodynamic Rescue of Cardiogenic Shock in RCA STEMI With Severe Mitral Regurgitation:
www.jacc.org
October 14, 2025 at 10:40 PM
Excited to share a new case report from my time in the CCU… we present a multidisciplinary management of a RCA STEMI complicated by cardiogenic shock, severe mitral regurgitation, and complete heart block.
www.jacc.org/doi/abs/10.1...
www.jacc.org/doi/abs/10.1...
“Nothing is so privileged as thinking history belongs to the past.”- John Green. Everything is Tuberculosis
September 3, 2025 at 1:09 AM
“Nothing is so privileged as thinking history belongs to the past.”- John Green. Everything is Tuberculosis
Found a nephrology textbook from 1859 at a bookstore. Even back then nephrologists loved saying there’s no such thing as normal urine labs, only normal serum labs.
August 29, 2025 at 4:49 PM
Found a nephrology textbook from 1859 at a bookstore. Even back then nephrologists loved saying there’s no such thing as normal urine labs, only normal serum labs.
Love this change in the new 2025 AHA HTN guidelines.
Hypertensive urgency completely removed.
Asymptomatic severe HTN as outpatient , DO NOT send to the emergency room, and more importantly if in the ED, NOT to give IV meds, nor admit. Much needed evidence based change.
Hypertensive urgency completely removed.
Asymptomatic severe HTN as outpatient , DO NOT send to the emergency room, and more importantly if in the ED, NOT to give IV meds, nor admit. Much needed evidence based change.
August 17, 2025 at 10:48 AM
Love this change in the new 2025 AHA HTN guidelines.
Hypertensive urgency completely removed.
Asymptomatic severe HTN as outpatient , DO NOT send to the emergency room, and more importantly if in the ED, NOT to give IV meds, nor admit. Much needed evidence based change.
Hypertensive urgency completely removed.
Asymptomatic severe HTN as outpatient , DO NOT send to the emergency room, and more importantly if in the ED, NOT to give IV meds, nor admit. Much needed evidence based change.